| scholarly article | Q13442814 |
| P50 | author | David Shu-cheong Hui | Q40358502 |
| Paul Kay-Sheung Chan | Q42915359 | ||
| Nelson L. Lee | Q47633764 | ||
| Wilson W. Tam | Q47820075 | ||
| Siu King Cheung | Q74141070 | ||
| Timothy M. Uyeki | Q84362200 | ||
| P2093 | author name string | Hui Li | |
| Bin Cao | |||
| Li Gu | |||
| Yee-Sin Leo | |||
| Jiuxin Qu | |||
| Yingmei Liu | |||
| W M Kyaw | |||
| Irene M H Yung | |||
| Zhenjia Liu | |||
| P2860 | cites work | Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies | Q28260818 |
| Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study | Q28269717 | ||
| Treating influenza with statins and other immunomodulatory agents. | Q30351911 | ||
| Influenza vaccination coverage rates among adults before and after the 2009 influenza pandemic and the reasons for non-vaccination in Beijing, China: a cross-sectional study | Q30351936 | ||
| The co-pathogenesis of influenza viruses with bacteria in the lung. | Q30359731 | ||
| Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. | Q30362392 | ||
| Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys. | Q30380132 | ||
| Pandemic (H1N1) 2009 surveillance and prevalence of seasonal influenza, Singapore | Q30383859 | ||
| Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. | Q30385962 | ||
| Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a Global Patient Registry. | Q30393490 | ||
| Clinical features of pneumonia caused by 2009 influenza A(H1N1) virus in Beijing, China | Q30394061 | ||
| Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China | Q30398438 | ||
| Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores | Q30401605 | ||
| Complications and outcomes of pandemic 2009 Influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza? | Q30403081 | ||
| Reducing occurrence and severity of pneumonia due to pandemic H1N1 2009 by early oseltamivir administration: a retrospective study in Mexico | Q30404888 | ||
| Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection | Q30405579 | ||
| Influenza disease burden in adults by subtypes following the initial epidemic of pandemic H1N1 in Singapore | Q30406608 | ||
| Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus | Q30412188 | ||
| Diagnosis, management and outcomes of adults hospitalized with influenza | Q30412653 | ||
| Reduced influenza antiviral treatment among children and adults hospitalized with laboratory-confirmed influenza infection in the year after the 2009 pandemic | Q30416134 | ||
| Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals | Q30426474 | ||
| Adjunctive therapies and immunomodulatory agents in the management of severe influenza | Q30429289 | ||
| Rosuvastatin for sepsis-associated acute respiratory distress syndrome | Q34559446 | ||
| Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study | Q34634314 | ||
| Chinese guidelines for diagnosis and treatment of influenza (2011) | Q35667872 | ||
| Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes. | Q36379603 | ||
| Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial | Q40152886 | ||
| Preventing and controlling influenza with available interventions. | Q42231920 | ||
| Statins and influenza: can we move forward? | Q43023894 | ||
| Outcomes of adults hospitalised with severe influenza. | Q43044944 | ||
| Assessing the effect of vaccine on spontaneous abortion using time-dependent covariates Cox models. | Q43756966 | ||
| Viral loads and duration of viral shedding in adult patients hospitalized with influenza. | Q43873120 | ||
| Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice | Q44752887 | ||
| Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). | Q45152293 | ||
| Determinants of antiviral effectiveness in influenza virus A subtype H5N1. | Q45355222 | ||
| Comparisons of oseltamivir-resistant (H275Y) and concurrent oseltamivir-susceptible seasonal influenza A(H1N1) virus infections in hospitalized adults, 2008-2009. | Q45356909 | ||
| Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. | Q45974600 | ||
| Influenza pneumonia among adolescents and adults: a concurrent comparison between influenza A (H1N1) pdm09 and A (H3N2) in the post-pandemic period. | Q51862891 | ||
| Influenza in the tropics | Q56880969 | ||
| Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality | Q57341509 | ||
| Dexamethasone in community-acquired pneumonia | Q59314227 | ||
| A Multicenter Randomized Trial of Atorvastatin Therapy in Intensive Care Patients with Severe Sepsis | Q59523516 | ||
| Preventing ventilator-associated pneumonia: An executive summary of the Association for Professionals in Infection Control and Epidemiology, Inc, Elimination Guide | Q85089797 | ||
| P433 | issue | 6 | |
| P921 | main subject | superinfection | Q1563808 |
| P304 | page(s) | 1642-1652 | |
| P577 | publication date | 2015-01-08 | |
| P1433 | published in | European Respiratory Journal | Q12257435 |
| P1476 | title | Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients | |
| P478 | volume | 45 |
| Q39414987 | A clinical approach to the threat of emerging influenza viruses in the Asia-Pacific region |
| Q40112217 | C-Reactive Protein Mediating Immunopathological Lesions: A Potential Treatment Option for Severe Influenza A Diseases |
| Q26782746 | Clinical Implications of Antiviral Resistance in Influenza |
| Q64134362 | Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa |
| Q90076721 | Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice |
| Q91861834 | Corticosteroids as adjunctive therapy in the treatment of influenza |
| Q36116778 | Corticosteroids for severe CAP: the pros |
| Q59351169 | Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration |
| Q53516441 | Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association. |
| Q38833321 | Early administration of neuraminidase inhibitors in adult patients hospitalized for influenza does not benefit survival: a retrospective cohort study |
| Q33838115 | Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A(H1N1)pdm09 viral pneumonia |
| Q30385450 | Epidemiology, Seasonality and Treatment of Hospitalized Adults and Adolescents with Influenza in Jingzhou, China, 2010-2012. |
| Q41025769 | High Viral Load and Respiratory Failure in Adults Hospitalized for Respiratory Syncytial Virus Infections. |
| Q30402044 | IFITM3, TLR3, and CD55 Genes SNPs and Cumulative Ge-netic Risks for Severe Outcomes in Chinese Patients with H7N9 / H1N1pdm09 Influenza |
| Q64936560 | Influenza virus-related critical illness: prevention, diagnosis, treatment. |
| Q38721361 | Pediatric bronchiectasis: No longer an orphan disease. |
| Q88616129 | Potential and challenges of serotherapy for severe influenza |
| Q47210194 | Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference |
| Q94547370 | Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines |
| Q92262820 | Severe acute respiratory infection risk following glucocorticosteroid treatment in uncomplicated influenza-like illness resulting from pH1N1 influenza infection: a case control study |
| Q64231311 | Severe acute respiratory infections (SARI) from influenza in adult patients in Chile: the experience of a sentinel hospital |
| Q92484231 | Severe flu management: a point of view |
| Q64111046 | The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis |
| Q47554935 | The role of adjuvant immunomodulatory agents for treatment of severe influenza |
| Q38587113 | Update in Viral Infections 2014. |
| Q89810484 | Use of corticosteroids in influenza-associated acute respiratory distress syndrome and severe pneumonia: a systemic review and meta-analysis |
| Q50437129 | What's new in severe community-acquired pneumonia? Corticosteroids as adjunctive treatment to antibiotics |
Search more.